Rebiotix Inc is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating gastrointestinal (GI) diseases by harnessing the power of the human microbiome. The company is on the forefront of an exciting potential medical breakthrough, Microbiota Restoration Therapy (MRT). MRT is the Rebiotix Drug Platform for delivering healthy, live, human-derived microbes into a sick patient’s intestinal tract to treat disease. Rebiotix looks to deliver on the promise of restoring the gut microbiota via a standardized and stabilized drug that has been developed and tested under the auspices of a regulatory authority.
Rebiotix was founded in 2011 and is headquartered in Roseville, US
Key People at Rebiotix
Latest funding size
Time since last funding
over 2 years
We estimate that Rebiotix's latest funding round in August 2014 was $25 M. In total, Rebiotix has raised $27.8 M
Market Position – Health, Technology, healthtech, biotech